Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Shares withheld for taxes President and CEO gave up 19,904 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Legal Officer gave up 184 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Development Officer gave up 403 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
  8. 4 Shares withheld for taxes President and CEO gave up 60,257 shares (to pay taxes)
  9. 4 Open-market sale 10% owner sold 736,767 shares at an average $1.38 ($1,017,919)
  10. 4 Open-market sale 10% owner sold 1,519,952 shares at an average $1.81 ($2,744,946)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 11 · 206 filings